Company profile for Immunai

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Immunai was founded in December 2018. We are a multidisciplinary team of immunologists, genomics technologists, computer scientists, engineers, mathematicians and operators singularly focused on solving an audacious challenge. Backed by some of the leading scientific minds in immunology, oncology, and single cell genomics, we are up for the challenge. Immunai combines comprehensive, multi-omic single cell genomics with cutting...
Immunai was founded in December 2018. We are a multidisciplinary team of immunologists, genomics technologists, computer scientists, engineers, mathematicians and operators singularly focused on solving an audacious challenge. Backed by some of the leading scientific minds in immunology, oncology, and single cell genomics, we are up for the challenge. Immunai combines comprehensive, multi-omic single cell genomics with cutting edge machine learning algorithms to enable high resolution profiling of the immune system, at industrial scale, with rapid turnaround.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
180 Varick St, 6th Fl New York, NY 10014
Telephone
Telephone
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.fiercebiotech.com/biotech/astrazeneca-pens-fresh-ibd-collab-long-term-ai-partner-immunai-worth-85m

FIERCE BIOTECH
17 Oct 2025

https://www.fiercebiotech.com/medtech/astrazeneca-extends-ai-immuno-oncology-rd-pact-immunai

FIERCE BIOTECH
26 Sep 2024

https://www.businesswire.com/news/home/20230515005607/en

BUSINESSWIRE
15 May 2023

https://endpts.com/koch-leads-mammoth-215m-infusion-into-ai-startup-boasting-largest-database-of-immune-cells/

Amber Tong ENDPTS
27 Oct 2021

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty